News

Event
Partner
Milestone
Partner
2019-07-29

ACT Genomics Collaborates with AIA Hong Kong to Promote Precision Cancer Medicine!

ACT Genomics is excited to collaborate with AIA Hong Kong to bring ACT Genomics’ leading cancer profiling service to AIA Hong Kong customers.

Place:

Taiwan

Event
2019-07-24

Welcome to Visit Us at BioAsia-Taiwan at M228

ACTGenomics presents precision medicine and cancer genomic profiling services at M228 in BioAsia-Taiwan. Welcome to visit us.

Place:

Taipei

Milestone
2019-07-18

ACT Genomics Wins Taiwan Bio Industry Organization Awards- Emerging Company of the Year

ACT Genomics drives innovation in global standard and individual markets, winning Taiwan Bio Industry Organization Awards- Emerging Company of the Year.

Place:

Taipei

Milestone
2019-07-05

ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park

ACT Genomics Holdings Co., Ltd, a leading cancer precision treatment solution provider, opened its third Next Generation Sequencing (“NGS”) laboratory in Asia at the Hong Kong Science Park, an innovation and technology centre spearheaded by HKSTP.

Place:

Hong Kong

Milestone
2019-04-19

ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

More precision cancer medicine are available for clinical needs and drug development in Japan! Find out more at the new analysis laboratory "Shonan iPark Laboratory" of ACTmed, a joint venture between Canon Medical Systems and ACT Genomics in Japan.

Place:

Japan

Milestone
2019-03-07

New Panel Launched: ACTBRCA HRD

ACTBRCA HRD is a new panel that sequences 48 genes including germline and somatic BRCA1/2, as well as other homologous recombination repair (HRR) genes, to assist physicians in identifying more patients for PARP inhibitors.

Place:

Milestone
2018-12-05

ACTOnco+ received National Innovation Award in Taiwan!

ACTOnco+ won the National Innovation Award in the the Precision Medicine section in Taiwan. ACTOnco+ was awarded for providing actionable solutions to cancer patients around Asia.

Place:

Taiwan

Event
2018-12-04

Come meet us at the Precision Medicine World Conference in Silicon Valley!

Chief Scientific Officer Dr. Shu Jen Chen will be presenting on "Biomarker Solution for Immunotherapy: TMB and Beyond" at the 16th PMWC on Jan 22nd, focusing on TMB and Tumor Micro-environment.

Place:

Silicon Valley, CA

Milestone
2018-11-24

ACT Genomics Completed Another Round of Equity Financing

ACT Genomics is pleased to announce the completion of the latest round of equity financing from a group of international investors co-led by CLSA Capital Partners to support the establishment of new CAP-accredited lab in HK, as well as R&D effort.

Place:

Milestone
2018-11-22

Dr. Allen Lai wins the Executive of the Year – Biotechnology award in Singapore

Dr. Allen Lai, Senior Vice President of ACT Genomics, wins the Executive of the Year – Biotechnology award in Singapore Business Review Management Excellence Awards 2018

Place:

Singapore